ESC Premium Access

Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry

Congress Session

About the speaker

Ms Karen Pieper

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

8 more presentations in this session

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation: a propensity-weighted cohort study

Speaker: Associate Professor E. Grove (Aarhus, DK)

Thumbnail

Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Impact of age > 75 years on one-year events in patients with atrial fibrillation and left atrial appendage occluder implantation. Results of the prospective LAARGE Registry

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)

Thumbnail

Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification

Speaker: Doctor A. Bisson (Tours, FR)

Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention - General

Speakers: Ms K. Pieper, Associate Professor E. Grove, Professor G. Lip, Professor U. Zeymer, Doctor X. Li...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk